[
  {
    "ts": null,
    "headline": "Fidelity Puritan Fund Q2 2025 Commentary",
    "summary": "Fidelity Investments reports a 7.73% Q2 gain for its Puritan Fund, driven by strong equity and bond picks. See how strategy paid off. Dive into the full review.",
    "url": "https://finnhub.io/api/news?id=fe9fbc9ccc93d1192019d6d23abd830936e3e965fc2a646f8912fd789ec0c251",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753825200,
      "headline": "Fidelity Puritan Fund Q2 2025 Commentary",
      "id": 136126693,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2164745342/image_2164745342.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Fidelity Investments reports a 7.73% Q2 gain for its Puritan Fund, driven by strong equity and bond picks. See how strategy paid off. Dive into the full review.",
      "url": "https://finnhub.io/api/news?id=fe9fbc9ccc93d1192019d6d23abd830936e3e965fc2a646f8912fd789ec0c251"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
    "summary": "Gilead Sciences Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=faeaaf96ab99d242f064f521823f655132f705038e45240ed3930f3f1ab6ffed",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753806960,
      "headline": "Gilead Sciences Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
      "id": 136135687,
      "image": "",
      "related": "GILD",
      "source": "MarketWatch",
      "summary": "Gilead Sciences Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=faeaaf96ab99d242f064f521823f655132f705038e45240ed3930f3f1ab6ffed"
    }
  },
  {
    "ts": null,
    "headline": "BMO says WSJ report on RFK potential headwind for Gilead",
    "summary": "BMO Capital keeps an Outperform rating Gilead (GILD) after the Wall Street Journal reported that Robert F. Kennedy Jr. plans to remove all members of the preventative services task force. The views the report as a potential headwind to Gilead, saying the Supreme Court’s Braidwood decision only concretized the power of RFK’s Department of Health and Human Services to decide what is necessary preventative care, rather than outright protecting pre-exposure prophylaxis. BMO says that while there was",
    "url": "https://finnhub.io/api/news?id=c8c1ee498e395b3c05af612cf2f5176d6f55b3747c6dcfb62548aba4ffc42582",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753797355,
      "headline": "BMO says WSJ report on RFK potential headwind for Gilead",
      "id": 136119352,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "BMO Capital keeps an Outperform rating Gilead (GILD) after the Wall Street Journal reported that Robert F. Kennedy Jr. plans to remove all members of the preventative services task force. The views the report as a potential headwind to Gilead, saying the Supreme Court’s Braidwood decision only concretized the power of RFK’s Department of Health and Human Services to decide what is necessary preventative care, rather than outright protecting pre-exposure prophylaxis. BMO says that while there was",
      "url": "https://finnhub.io/api/news?id=c8c1ee498e395b3c05af612cf2f5176d6f55b3747c6dcfb62548aba4ffc42582"
    }
  }
]